All quotes are delayed by at least 15 minutes.
MarketGrader Top Down Analysis
Sector Analysis - BSX ranks 373 out of 578 stocks in the sector
Industry Analysis - BSX ranks 120 out of 184 stocks in the industry
| Boston Scientific Corporation |
Key Financials |
Relative to Peer Avg |
| Quarterly Revenue Growth |
-5.63% |
|
| Annual Revenue Growth |
-12.20% |
|
| Quarterly Net Income Growth |
-413.27% |
|
| Annual Net Income Growth |
74.42% |
|
| Quarterly Free Cash Flow Growth |
|
|
| Total Debt Relative to Total Capital |
39.56% |
|
| Operating Margin |
12.21% |
 Below |
| Return on Equity |
-69.737% |
|
| Boston Scientific Corporation (BSX) Dilution Analysis |
| Latest EPS |
-$0.26 |
|
-$0.02 |
Top Competitors
| Company |
Revenue* |
Net Income* |
Rating |
Sentiment |
| ABT |
5,377.90 |
544.66 |
Sign up to view |
| MDT |
4,027.00 |
988.00 |
Sign up to view |
| BAX |
3,448.00 |
552.00 |
Sign up to view |
| TMO |
3,191.50 |
340.40 |
Sign up to view |
| COV |
3,103.00 |
439.00 |
Sign up to view |
| SYK |
2,190.00 |
304.00 |
Sign up to view |
| BDX |
2,000.38 |
275.64 |
Sign up to view |
| BSX |
1,761.00 |
-354.00 |
Sign up to view |
| STJ |
1,338.00 |
223.00 |
Sign up to view |
| ZMH |
1,138.90 |
218.60 |
Sign up to view |
*Revenue and Net Income figures are based on latest quarterly financials.
Sign up for complete Sentiment Analysis
Sign up for complete Fundamental Analysis
